Activation of mitogen-activated protein kinases in experimental cerebral ischemia

被引:74
作者
Lennmyr, F [1 ]
Karlsson, S
Gerwins, P
Ata, KA
Terént, A
机构
[1] Univ Uppsala Hosp, Dept Anesthesiol & Intens Care, SE-75185 Uppsala, Sweden
[2] Univ Uppsala Hosp, Dept Med Sci, SE-75185 Uppsala, Sweden
[3] Univ Uppsala Hosp, Dept Genet & Pathol, SE-75185 Uppsala, Sweden
来源
ACTA NEUROLOGICA SCANDINAVICA | 2002年 / 106卷 / 06期
关键词
immunohistochemistry; ischemia-reperfusion; middle cerebral artery occlusion (MCAO); mitogen-activated protein kinase (MAPK); rat;
D O I
10.1034/j.1600-0404.2002.01313.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives - Mitogen-activated protein kinases ( MAPK) regulate cell survival and differentiation. The aim of the present study is to investigate the activation pattern of different MAPKs [extracellular signal-regulated kinase (ERK), c-jun-N-terminal kinase (JNK) and p38] after cerebral ischemia. Material and methods - Rats were subjected to cerebral ischemia using a model for transient (2 h) and permanent middle cerebral artery occlusion (MCAO). The rats were allowed 6 h to 1 week of survival before immunohistochemical evaluation with phospho-specific antibodies, recognizing activated MAPKs. Results - ERK was activated in ipsilateral blood vessels, neurons and glia, but also in contralateral vessels. JNK activation was absent in neurons but appeared in arterial blood vessels and glia at the lesion side. Active p38 was observed in macrophages in maturing infarcts. Conclusions - ERK and JNK may participate in the angiogenic response to cerebral ischemia. ERK, but not JNK, was activated in neurons, possibly indicating a pathophysiologic role. Active p38 might be involved in the inflammatory reaction.
引用
收藏
页码:333 / 340
页数:8
相关论文
共 47 条
[1]   MEK1 protein kinase inhibition protects against damage resulting from focal cerebral ischemia [J].
Alessandrini, A ;
Namura, S ;
Moskowitz, MA ;
Bonventre, JV .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (22) :12866-12869
[2]  
Anderson CNG, 1999, J NEUROSCI, V19, P664
[3]  
Barone FC, 2001, MED RES REV, V21, P129, DOI 10.1002/1098-1128(200103)21:2<129::AID-MED1003>3.0.CO
[4]  
2-H
[5]  
Barone FC, 2001, J PHARMACOL EXP THER, V296, P312
[6]   ERKS - A FAMILY OF PROTEIN-SERINE THREONINE KINASES THAT ARE ACTIVATED AND TYROSINE PHOSPHORYLATED IN RESPONSE TO INSULIN AND NGF [J].
BOULTON, TG ;
NYE, SH ;
ROBBINS, DJ ;
IP, NY ;
RADZIEJEWSKA, E ;
MORGENBESSER, SD ;
DEPINHO, RA ;
PANAYOTATOS, N ;
COBB, MH ;
YANCOPOULOS, GD .
CELL, 1991, 65 (04) :663-675
[7]   The p38 pathway provides negative feedback for Ras proliferative signaling [J].
Chen, G ;
Hitomi, M ;
Han, JH ;
Stacey, DW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (50) :38973-38980
[8]   Prolactin-induced cell proliferation in PC12 cells depends on JNK but not ERK activation [J].
Cheng, Y ;
Zhizhin, I ;
Perlman, RL ;
Mangoura, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (30) :23326-23332
[9]   Chromogranin A induces a neurotoxic phenotype in brain microglial cells [J].
Ciesielski-Treska, J ;
Ulrich, G ;
Taupenot, L ;
Chasserot-Golaz, S ;
Corti, A ;
Aunis, D ;
Bader, MF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (23) :14339-14346
[10]   A permissive role for tumor necrosis factor in vascular endothelial growth factor-induced vascular permeability [J].
Clauss, M ;
Sunderkötter, C ;
Sveinbjörnsson, B ;
Hippenstiel, S ;
Willuweit, A ;
Marino, M ;
Haas, E ;
Seljelid, R ;
Scheurich, P ;
Suttorp, N ;
Grell, M ;
Risau, W .
BLOOD, 2001, 97 (05) :1321-1329